SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000899866-21-000021
Filing Date
2021-02-16
Accepted
2021-02-16 17:02:44
Documents
14
Period of Report
2021-02-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K alxn-20210216.htm   iXBRL 8-K 30198
  Complete submission text file 0000899866-21-000021.txt   171414

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alxn-20210216.xsd EX-101.SCH 2452
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alxn-20210216_cal.xml EX-101.CAL 741
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alxn-20210216_def.xml EX-101.DEF 1687
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alxn-20210216_lab.xml EX-101.LAB 24275
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alxn-20210216_pre.xml EX-101.PRE 12677
7 EXTRACTED XBRL INSTANCE DOCUMENT alxn-20210216_htm.xml XML 10826
Mailing Address 121 SEAPORT BOULEVARD BOSTON MA 02210
Business Address 121 SEAPORT BOULEVARD BOSTON MA 02210 4752302596
ALEXION PHARMACEUTICALS, INC. (Filer) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27756 | Film No.: 21640516
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences